Elevance Health, Inc.
ELV
$289.10
$8.673.09%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.24% | 14.70% | 3.10% | 4.50% | -2.92% |
| Total Other Revenue | 3.85% | 15.55% | 24.21% | 9.69% | 15.82% |
| Total Revenue | 14.04% | 14.83% | 6.55% | 5.36% | -0.06% |
| Cost of Revenue | 20.06% | 15.60% | 6.91% | 7.66% | -3.27% |
| Gross Profit | -0.03% | 12.87% | 5.56% | -0.38% | 8.34% |
| SG&A Expenses | 4.09% | 18.05% | 23.96% | -0.24% | 8.10% |
| Depreciation & Amortization | -9.26% | 33.62% | -17.05% | -42.45% | -26.70% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.06% | 16.20% | 10.47% | 5.45% | -0.85% |
| Operating Income | -12.99% | -1.97% | -58.94% | 3.50% | 11.99% |
| Income Before Tax | -23.24% | -4.83% | -39.46% | -16.99% | 22.33% |
| Income Tax Expenses | -20.00% | -11.16% | 13.53% | 3.11% | 17.09% |
| Earnings from Continuing Operations | -24.21% | -2.89% | -50.30% | -22.46% | 23.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | 66.67% | -80.00% | 172.73% | 66.67% |
| Net Income | -24.22% | -2.80% | -51.17% | -21.18% | 24.12% |
| EBIT | -12.99% | -1.97% | -58.94% | 3.50% | 11.99% |
| EBITDA | -10.35% | -0.59% | -51.03% | -1.28% | 7.21% |
| EPS Basic | -21.86% | -0.10% | -50.18% | -20.02% | 26.50% |
| Normalized Basic EPS | -13.95% | -2.08% | -69.41% | 4.96% | 14.81% |
| EPS Diluted | -21.62% | 0.21% | -50.17% | -20.00% | 26.44% |
| Normalized Diluted EPS | -13.73% | -1.80% | -69.41% | 4.96% | 14.77% |
| Average Basic Shares Outstanding | -3.01% | -2.71% | -1.99% | -1.44% | -1.88% |
| Average Diluted Shares Outstanding | -3.26% | -2.99% | -1.99% | -1.44% | -1.85% |
| Dividend Per Share | 4.91% | 4.91% | 10.14% | 10.14% | 10.14% |
| Payout Ratio | 0.34% | 0.05% | 1.21% | 0.38% | -0.13% |